Quest Magazine

UPDATE: DMD: Eteplirsen Shows Continued Benefit at 84 Weeks

Eighth Annual Tradition Of Hope Gala To Support MDA's Augie's Quest

ALS Briefs: Neuralstem, Body Fat, Behavior, Respiratory Care

This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

Titin Mutations Can Cause CNM

Researchers in the United States and France, supported in part by MDA, have established that mutations in the titin gene are a cause of centronuclear myopathy (CNM), a group of muscle disorders characterized by variable degrees of weakness and cell nuclei that are abnormally located toward the center of muscle fibers rather than around the perimeter.

DMD: Experimental Exon-Skipping Drug Drisapersen Disappoints

A large-scale, phase 3 trial of the experimental exon-skipping drug drisapersen, in development to treat Duchenne muscular dystrophy (DMD), found no statistically significant differences on tests of walking distance or motor function between trial participants treated with the drug and those treated with a placebo.

Mouse Model of Adult-Onset SMA Encourages Researchers

'Gentler' Corticosteroid Drug Shows Promise in DMD Mice

A drug that may provide the benefits of corticosteroid medications such as prednisone and deflazacort without some of their notorious side effects — growth retardation, bone loss and suppression of the immune system — has been shown to protect and strengthen muscles in mice with a disease that mimics Duchenne muscular dystrophy (DMD).

MDA Offers Free Flu Shots to Those Affected by Muscle Disease

ALS Briefs: Diet, Autoimmune Disease, ALS TDI, Neuralstem, Cytokinetics

This roundup of recent amyotrophic lateral sclerosis (ALS) research and clinical trials news includes:

2013 BMD Conference Covered Research, Medical Care and Daily Life

The 2013 MDA-supported Becker Muscular Dystrophy Conference, held Aug. 24 in Baltimore and co-hosted by MDA and Johns Hopkins Medicine, was "high-energy" with "phenomenal" presenters, says Annie Kennedy, MDA's senior vice president of advocacy, who attended and helped organize the meeting.

Some 130 people attended in person and many more, including some from outside the United States, attended online.

Pages